Vaccine Candidate Effective in Preventing Against RSV, Phase 2a Study Finds
July 19th 2022Results from a phase 2a study show that a bivalent prefusion F vaccine was effective against symptomatic respiratory syncytial virus (RSV) infection and viral shedding, with no identified safety concerns.
Read More
What We’re Reading: COVID-19 Cruise Reporting; 2023 Health Plan Costs; Drug Price Control Battle
July 19th 2022The CDC will no longer report COVID-19 case levels on cruises; some health plans are projected to increase their plan premiums by an average of 10%; a proposed plan to curb drug prices could save the US government $288 billion over the next decade.
Read More
Too Little Salt May Have an Adverse Impact on People Living With HFpEF
July 18th 2022This new study investigated the impact of overly restrictive salt-intake guidelines on patients living with heart failure with preserved ejection fraction (HFpEF), because despite accounting for half of all HF cases, this patient population is often excluded from studies in the space.
Read More
Difference in eGFR Values Based on Cystatin C vs Creatinine Could Indicate Higher HF Risk
July 18th 2022A prospective cohort study found that in patients with chronic kidney disease, large differences in their glomerular filtration rate (eGFR) based on cystatin C vs creatinine were associated with risk of incident heart failure (HF).
Read More
Using AI to Screen for Preventable Infant Blindness in Underresourced Countries
July 18th 2022A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.
Read More
Anthony Fauci, MD says he will retire when President Joe Biden’s current term ends; the overturning of Roe v Wade has affected access to medicines outside of abortions; former FDA Commissioner Scott Gottlieb, MD, warns that the window for monkeypox containment may have closed.
Read More
Dr Sabin Dang Outlines the Additional Practice Burdens of Prior Authorizations
July 17th 2022While prior authorizations are put in place to ensure appropriate use of expensive therapies, they create a substantial burden for clinicians and patients, said Sabin Dang, MD, ophthalmologist with The Retina Institute.
Watch
Contributor: Charting a New Path to At-Home Medication Adherence With Digital Pharmacy Support
July 17th 2022Polypharmacy and medication adherence are common problems among the Medicare patient population, and this article addresses how Medicare Advantage plans can address these challenges and improve patient outcomes.
Read More
Patients Lost to Follow-up and Perspectives on Telehealth for Retinal Disease During COVID-19
July 17th 2022Two posters presented at the American Society of Retina Specialists 40th Annual Scientific Meeting evaluated the impact of the COVID-19 pandemic on rates of patients lost to follow-up and patient perspectives regarding telehealth for retinal disease.
Read More
ASRS Posters Review Long-term Visual Outcomes, Treatment Burden of Anti-VEGF Therapies
July 16th 2022Posters presented at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting evaluated the association between long-term visual acuity outcomes and use of anti–vascular endothelial growth factor (VEGF) therapy, as well as patient and caregiver experience with ant-VEGF.
Read More
Dr Elaine Goodman on What COVID-19 Taught Her About Digital Health Management
July 16th 2022Elaine Goodman, MD, MBA, clinical lead for population health management at Mass General Brigham, talks about how the COVID-19 pandemic should impact developments in digital health management going forward.
Watch
Identifying Long-term Treatment Patterns of Anti-VEGF for DME and the Ideal Dosing Paradigm
July 16th 2022While anti–vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME), a majority of patients discontinue therapy after 6 months and there is no consensus on the ideal dosing paradigm.
Read More
Use of Local Skin Flaps May Lead to Reduced Risk of Scarring Following Mohs Surgery
July 16th 2022Three methods of cosmetic surgery—local skin flap, full thickness skin graft, and secondary intention—were evaluated for their scarring risk following Mohs microscopic surgery on the distal third of the nose.
Read More
Dr Jonathan Kentley Discusses Training Algorithms to Detect Melanoma
July 16th 2022Many algorithms claiming to identify melanoma better than dermatologists are trained on retrospective datasets, which is not reflective of real-world clinical practice, said Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center.
Watch
Impact of Health Literacy on Teaching Correct Inhaler Use in COPD, Asthma
July 16th 2022A recent study found that teach-to-goal methods are more effective than brief interventions in metered-dose inhaler education for patients with chronic obstructive pulmonary disease (COPD) and asthma, but results may vary depending on levels of health literacy.
Read More
Predicting Visual Outcomes and Visual Improvement in Macular Edema Due to CRVO
July 16th 2022A machine learning model was able to predict visual outcomes and showed that the time from diagnosis to first treatment indicates visual improvement in patients with macular edema due to central retinal vein occlusion (CRVO).
Read More
Survey Finds Shift in Clinician Views of MRD Status in Treatment Decisions for Multiple Myeloma
July 16th 2022Results looking at acceptance of minimal residual disease (MRD) status found that 60% of participants “would change at least one decision based on an MRD result,” and 54% would use both MRD status and disease risk to make decisions.
Read More